Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma: A Pooled Analysis
Mangla, Ankit, Lee, Chanmi, Mirsky, Matthew M, Wang, Margaret, Rothermel, Luke D, Hoehn, Richard, Bordeaux, Jeremy S, Carrol, Bryan T, Theuner, Jason, Li, Shawn, Fu, Pingfu, Kirkwood, John M
Published in JAMA oncology (01.05.2024)
Published in JAMA oncology (01.05.2024)
Get more information
Journal Article
Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status
Mirsky, Matthew M, Mitchell, Carley, Hong, Augustine, Cao, Shufen, Fu, Pingfu, Margevicius, Seunghee, Wu, Sulin, Dowlati, Afshin, Nelson, Ariel, Selfridge, J. Eva, Ramaiya, Nikhil, Hoimes, Christopher, Alahmadi, Asrar, Bruno, Debora S
Published in Cancer management and research (01.09.2023)
Published in Cancer management and research (01.09.2023)
Get full text
Journal Article
The effect of various social determinants of health on overall survival in the SCLC population
Mirsky, Matthew M, Lee, Chan Mi, Li, Joy, Mitchell, Carley, Zhang, Annie, Zhong, Jeffrey, Fu, Pingfu, Margevicius, Seunghee P, Cullen, Jennifer, Dowlati, Afshin, Hsu, Melinda Laine
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Treatment outcomes in locally advanced, unresectable NSCLC treated with concurrent chemoradiation and PD-L1 consolidation: Real-world data from a NCI comprehensive cancer center with a racially diverse, high poverty catchment area
Mirsky, Matthew M., Lee, Ho Jun, Margevicius, Seunghee P, Carsel, Alex, Myers, Katherine, Zablonski, Kevin, Zhong, Jeffrey, Fu, Pingfu, Wang, Qian, Dowlati, Afshin, Bruno, Debora S., Hsu, Melinda Laine
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article